Report cover image

Global Inactivated Polio and Rabies Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 189 Pages
SKU # APRC20355844

Description

Summary

According to APO Research, The global Inactivated Polio and Rabies Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inactivated Polio and Rabies Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Inactivated Polio and Rabies Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Inactivated Polio and Rabies Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Inactivated Polio and Rabies Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Kedrion Biopharma, Serum Institute of India, GlaxoSmithKline, Pfizer and Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inactivated Polio and Rabies Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Inactivated Polio and Rabies Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Inactivated Polio and Rabies Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inactivated Polio and Rabies Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Inactivated Polio and Rabies Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Inactivated Polio and Rabies Vaccines sales, projected growth trends, production technology, application and end-user industry.

Inactivated Polio and Rabies Vaccines Segment by Company

Bharat Biotech
BIO-MED
Kedrion Biopharma
Serum Institute of India
GlaxoSmithKline
Pfizer
Merck
Inactivated Polio and Rabies Vaccines Segment by Type

Inactivated Polio Vaccine
Inactivated Rabies Vaccine
Inactivated Polio and Rabies Vaccines Segment by Application

Pediatrics
Adults
Inactivated Polio and Rabies Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Polio and Rabies Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inactivated Polio and Rabies Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Polio and Rabies Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inactivated Polio and Rabies Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Polio and Rabies Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inactivated Polio and Rabies Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Inactivated Polio and Rabies Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

189 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Inactivated Polio and Rabies Vaccines Market Size, 2020 VS 2024 VS 2031
1.3 Global Inactivated Polio and Rabies Vaccines Market Size Estimates and Forecasts (2020-2031)
1.4 Global Inactivated Polio and Rabies Vaccines Sales Estimates and Forecasts (2020-2031)
1.5 Global Inactivated Polio and Rabies Vaccines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Inactivated Polio and Rabies Vaccines Market Dynamics
2.1 Inactivated Polio and Rabies Vaccines Industry Trends
2.2 Inactivated Polio and Rabies Vaccines Industry Drivers
2.3 Inactivated Polio and Rabies Vaccines Industry Opportunities and Challenges
2.4 Inactivated Polio and Rabies Vaccines Industry Restraints
3 Inactivated Polio and Rabies Vaccines Market by Manufacturers
3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturers (2020-2025)
3.2 Global Inactivated Polio and Rabies Vaccines Sales by Manufacturers (2020-2025)
3.3 Global Inactivated Polio and Rabies Vaccines Average Sales Price by Manufacturers (2020-2025)
3.4 Global Inactivated Polio and Rabies Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Inactivated Polio and Rabies Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Inactivated Polio and Rabies Vaccines Manufacturers, Product Type & Application
3.7 Global Inactivated Polio and Rabies Vaccines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Inactivated Polio and Rabies Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Inactivated Polio and Rabies Vaccines Players Market Share by Revenue in 2024
3.8.3 2024 Inactivated Polio and Rabies Vaccines Tier 1, Tier 2, and Tier 3
4 Inactivated Polio and Rabies Vaccines Market by Type
4.1 Inactivated Polio and Rabies Vaccines Type Introduction
4.1.1 Inactivated Polio Vaccine
4.1.2 Inactivated Rabies Vaccine
4.2 Global Inactivated Polio and Rabies Vaccines Sales by Type
4.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Type (2020-2031)
4.2.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2020-2031)
4.3 Global Inactivated Polio and Rabies Vaccines Revenue by Type
4.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2020-2031)
4.3.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2020-2031)
5 Inactivated Polio and Rabies Vaccines Market by Application
5.1 Inactivated Polio and Rabies Vaccines Application Introduction
5.1.1 Pediatrics
5.1.2 Adults
5.2 Global Inactivated Polio and Rabies Vaccines Sales by Application
5.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Application (2020-2031)
5.2.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2020-2031)
5.3 Global Inactivated Polio and Rabies Vaccines Revenue by Application
5.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2020-2031)
5.3.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2020-2031)
6 Global Inactivated Polio and Rabies Vaccines Sales by Region
6.1 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Inactivated Polio and Rabies Vaccines Sales by Region (2020-2031)
6.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Region (2020-2025)
6.2.2 Global Inactivated Polio and Rabies Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Inactivated Polio and Rabies Vaccines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Inactivated Polio and Rabies Vaccines Revenue by Region
7.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region
7.1.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2020-2025)
7.1.3 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2026-2031)
7.1.4 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Inactivated Polio and Rabies Vaccines Revenue (2020-2031)
7.2.2 North America Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Inactivated Polio and Rabies Vaccines Revenue (2020-2031)
7.3.2 Europe Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue (2020-2031)
7.4.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Bharat Biotech
8.1.1 Bharat Biotech Comapny Information
8.1.2 Bharat Biotech Business Overview
8.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio
8.1.5 Bharat Biotech Recent Developments
8.2 BIO-MED
8.2.1 BIO-MED Comapny Information
8.2.2 BIO-MED Business Overview
8.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio
8.2.5 BIO-MED Recent Developments
8.3 Kedrion Biopharma
8.3.1 Kedrion Biopharma Comapny Information
8.3.2 Kedrion Biopharma Business Overview
8.3.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio
8.3.5 Kedrion Biopharma Recent Developments
8.4 Serum Institute of India
8.4.1 Serum Institute of India Comapny Information
8.4.2 Serum Institute of India Business Overview
8.4.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio
8.4.5 Serum Institute of India Recent Developments
8.5 GlaxoSmithKline
8.5.1 GlaxoSmithKline Comapny Information
8.5.2 GlaxoSmithKline Business Overview
8.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio
8.5.5 GlaxoSmithKline Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 Merck
8.7.1 Merck Comapny Information
8.7.2 Merck Business Overview
8.7.3 Merck Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Merck Inactivated Polio and Rabies Vaccines Product Portfolio
8.7.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Inactivated Polio and Rabies Vaccines Value Chain Analysis
9.1.1 Inactivated Polio and Rabies Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Inactivated Polio and Rabies Vaccines Production Mode & Process
9.2 Inactivated Polio and Rabies Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Inactivated Polio and Rabies Vaccines Distributors
9.2.3 Inactivated Polio and Rabies Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.